BioTrace Medical
831 Bransten Road
Suite L
San Carlos
California
94070
United States
Tel: 650-779-4999
Website: http://www.biotracemedical.com/
About BioTrace Medical
BioTrace Medical, a venture backed company based in San Carlos, Calif., is dedicated to reinventing temporary pacing to improve patient outcomes and reduce hospital costs.YEAR FOUNDED:
2013
LEADERSHIP:
Founder: Ellis Garai
Founder: Aravind Swaminathan
President & CEO: Laura N. Dietch
10 articles about BioTrace Medical
-
Experience with BioTrace Medical’s Tempo Temporary Pacing Lead in Mitral Valve Surgeries Presented at Society of Cardiovascular Anesthesiologists’ 43rd Annual Meeting
4/26/2021
Experience with BioTrace Medical’s Tempo Temporary Pacing Lead in Mitral Valve Surgeries Presented at Society of Cardiovascular Anesthesiologists’ 43 rd Annual Meeting
-
BioTrace Medical Announces Key Events Featuring Tempo Temporary Pacing Lead at TCT 2019
9/19/2019
BioTrace Medical, Inc., the leader in innovative temporary pacing technology, today announced the company’s key activities at the 31st annual Transcatheter Cardiovascular Therapeutics (TCT) conference, which will take place September 25-29 in San Francisco.
-
BioTrace Medical Announces Key Events Featuring Tempo Temporary Pacing Lead at TVT 2019
6/5/2019
New TAVR standard of care technology to be featured in lunch symposium, live cases, and podium presentation
-
BioTrace Medical’s Tempo Lead Obtains CE Mark for Safe and Secure Temporary Intracardiac Pacing
5/8/2019
BioTrace Medical, Inc., the leader in innovative temporary pacing technology, today announced the company’s Tempo® Lead has obtained CE Mark certification in Europe for use in cardiac procedures requiring temporary intracardiac pacing.
-
BioTrace Medical Announces Key Events Featuring Tempo® Lead at TCT 2018
9/18/2018
Company’s Tempo Temporary Pacing Lead Has Been Used in More Than 1,500 Procedures with No Perforations – New Standard of Care in TAVR Demonstrates Safe Ambulation and Contributes to Reduced Length of Stay
-
BioTrace Medical Announces Key Events Featuring Tempo® Lead at TVT 2018
6/18/2018
Presentations Will Highlight Use of Tempo Lead as New Standard of Care in Temporary Pacing That Results in Earlier Ambulation and Reduced Length of Stay
-
Safety and Effectiveness of BioTrace Medical’s Tempo® Lead Further Demonstrated in Multi-Center Analysis of More Than 200 Cardiac Procedures
3/1/2018
U.S. Multi-Center Study Confirms Previous Intra-Procedural Safety; Post-TAVR Temporary Pacing Demonstrates Ambulation Capabilities
-
BioTrace Medical’s Tempo Lead Shows Stability And Safety In Real-World Performance Consistent With Clinical Study Outcomes In TVT 2017 Presentation
6/19/2017
-
BioTrace Medical Announces Positive Data From Clinical Study Of Innovative Temporary Pacing Technology For Transcatheter Aortic Valve Procedures And Other Cardiovascular Applications
10/31/2016
-
Bay Area's BioTrace Medical Nabs FDA Clearance of Innovative Temporary Pacing Technology for the Heart
10/27/2016